A phase 2a trial of brepocitinib for cicatricial alopecia
{{output}}
Background: Cicatricial alopecias are chronic, progressive scarring hair-loss conditions. Molecular dysregulation is not fully understood, hindering treatment development. Th1/IFNγ signaling and Janus kinase dysregulation has sh... ...
